BlackRock’s Tourmaline Bio TRML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.1M | Sell |
1,633,942
-158,266
| -9% | -$2.53M | ﹤0.01% | 2809 |
|
|
2025
Q1 | $27.3M | Sell |
1,792,208
-11,692
| -0.6% | -$178K | ﹤0.01% | 2723 |
|
|
2024
Q4 | $36.6M | Buy |
1,803,900
+50,553
| +3% | +$1.03M | ﹤0.01% | 2620 |
|
|
2024
Q3 | $45.1M | Buy |
1,753,347
+29,131
| +2% | +$749K | ﹤0.01% | 2498 |
|
|
2024
Q2 | $22.2M | Buy |
1,724,216
+1,228,841
| +248% | +$15.8M | ﹤0.01% | 2877 |
|
|
2024
Q1 | $11.3M | Buy |
495,375
+222,999
| +82% | +$5.11M | ﹤0.01% | 3234 |
|
|
2023
Q4 | $7.13M | Buy |
272,376
+259,693
| +2,048% | +$6.8M | ﹤0.01% | 3474 |
|
|
2023
Q3 | $356K | Sell |
12,683
-356
| -3% | -$10K | ﹤0.01% | 4447 |
|
|
2023
Q2 | $396K | Sell |
13,039
-103,448
| -89% | -$3.14M | ﹤0.01% | 4465 |
|
|
2023
Q1 | $2.19M | Buy |
116,487
+6,532
| +6% | +$123K | ﹤0.01% | 3936 |
|
|
2022
Q4 | $1.12M | Sell |
109,955
-88,819
| -45% | -$906K | ﹤0.01% | 4296 |
|
|
2022
Q3 | $5.23M | Sell |
198,774
-53,287
| -21% | -$1.4M | ﹤0.01% | 3662 |
|
|
2022
Q2 | $11.4M | Buy |
252,061
+8,670
| +4% | +$391K | ﹤0.01% | 3363 |
|
|
2022
Q1 | $24M | Buy |
243,391
+3,844
| +2% | +$378K | ﹤0.01% | 2994 |
|
|
2021
Q4 | $36.6M | Buy |
239,547
+66,364
| +38% | +$10.1M | ﹤0.01% | 2837 |
|
|
2021
Q3 | $23.5M | Sell |
173,183
-4,130
| -2% | -$560K | ﹤0.01% | 3123 |
|
|
2021
Q2 | $26M | Buy |
+177,313
| New | +$26M | ﹤0.01% | 3090 |
|